文献速递肾移植慢性肾脏病

2021年免种族CKD-EPI肌酐与胱抑素C估算GFR方程在肾移植受者中的表现

Performance of the 2021 Race-Free CKD-EPI Creatinine- and Cystatin C-Based Estimated GFR Equations Among Kidney Transplant Recipients.
PubMed 文献 · Am J Kidney Dis · 2022-05-16

该横断面研究在415例加拿大和新西兰稳定期肾移植受者中验证2021年免种族CKD-EPI eGFR方程,与2009/2012版及MDRD方程比较,发现新旧方程偏差、精度和准确性相似,2021年eGFRcr与eGFRcr-cys方程间无显著差异。

要点

  • 2021免种族CKD-EPI eGFRcr与2009版在肾移植受者中偏差、精度和准确性相似。
  • 2021免种族CKD-EPI eGFRcr-cys与2012版在肾移植受者中表现相似。
  • 2021年eGFRcr与eGFRcr-cys方程在肾移植人群中未检测到明显性能差异。

核心结论

  • 在肾移植受者中,2021年免种族CKD-EPI eGFR方程与含种族校正项的既往CKD-EPI方程表现相似。
  • 2021年CKD-EPI eGFRcr与eGFRcr-cys方程在肾移植人群中未观察到显著性能差异。

研究设计与样本

  • 横断面研究,在加拿大和新西兰的稳定期肾移植受者(N=415)中验证2021年免种族CKD-EPI eGFR方程。
  • 同日测量肌酐、胱抑素C,并使用放射性标记二乙烯三胺五乙酸测定GFR。

主要发现

  • 2009与2021版CKD-EPI eGFRcr方程中位偏差分别为-2.3与-0.2 mL/min/1.73 m2,精度分别为14.5与14.9 mL/min/1.73 m2,P10/P20/P30分别为32%/65%/84%与33%/63%/84%。
  • 2012与2021版CKD-EPI eGFRcr-cys方程中位偏差分别为-3.6与0.3 mL/min/1.73 m2,精度分别为13.3与14.3 mL/min/1.73 m2,P10/P20/P30分别为32%/63%/80%与32%/67%/83%。
  • 2021年CKD-EPI eGFRcr与eGFRcr-cys方程在肾移植受者中未检测到明显性能差异。
  • 所有eGFR方程按CKD分期的正确分类比例相似。

关键数值与推荐

  • 研究人群87%为白人,3%为黑人,10%为其他种族。
  • 平均实测GFR为53 ± 19(标准差)mL/min/1.73 m2。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 样本量中等。
  • 少数患者GFR <30 mL/min/1.73 m2。
  • 绝大多数患者为白人。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Race-free estimated glomerular filtration rate (eGFR) equations incorporating creatinine with and without cystatin C were recently developed and recommended for routine use. However, the performance of these equations among kidney transplant recipients (KTRs) remains unknown. STUDY DESIGN: Cross-sectional study to validate the 2021 race-free Chronic Kidney Disease (CKD) Epidemiology Collaboration (CKD-EPI) eGFR equation based on creatinine alone (eGFRcr) or based on creatinine and cystatin C (eGFRcr-cys) among KTRs. SETTING & PARTICIPANTS: KTRs in stable condition (N = 415) from Canada and New Zealand with same-day measurements of creatinine, cystatin C, and glomerular filtration rate (GFR) using radiolabeled diethylenetriaminepentaacetic acid. TESTS COMPARED: The 2009 CKD-EPI eGFRcr, 2021 CKD-EPI eGFRcr, 2012 CKD-EPI eGFRcr-cys, 2021 CKD-EPI eGFRcr-cys, 2012 CKD-EPI eGFRcys, and Modification of Diet in Renal Disease (MDRD) Study eGFR equations were compared with measured GFR. OUTCOMES: Bias, precision, accuracy, and correct classification by CKD stage. Bias was defined as the difference between estimated and measured GFR. Precision was represented by the interquartile range. Accuracy was defined as the percentages of participants with eGFRs within 10%/20%/30% (P10/P20/P30) of measured GFR, root mean square error, and mean absolute error. RESULTS: 87% of patients studied were White, 3% Black, and 10% other races. Mean measured GFR was 53 ± 19 (SD) mL/min/1.73 m2. The 2009 and 2021 CKD-EPI eGFRcr equations demonstrated similar median bias (-2.3 vs -0.2 mL/min/1.73 m2, respectively), precision (14.5 vs 14.9 mL/min/1.73 m2), and accuracy (P10/P20/P30, 32%/65%/84% vs 33%/63%/84%). The 2012 and 2021 CKD-EPI eGFRcr-cys equations also demonstrated similar median bias (-3.6 vs 0.3 mL/min/1.73 m2, respectively), precision (13.3 vs 14.3 mL/min/1.73 m2), and accuracy (P10/P20/P30, 32%/63%/80% vs 32%/67%/83%). No clear difference in performance was detected between the 2021 CKD-EPI eGFRcr and eGFRcr-cys equations among KTRs. The proportion of correct classification by CKD stage was similar across all eGFR equations. LIMITATIONS: Moderate sample size, few patients had a GFR <30 mL/min/1.73 m2, and the large majority of patients were White. CONCLUSIONS: Among KTRs, the 2021 race-free CKD-EPI eGFR equations perform similarly to the previous CKD-EPI equations that included race correction terms. No significant difference in performance was observed between the 2021 CKD-EPI eGFRcr and eGFRcr-cys equations in the kidney transplant population.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Hundemer GL, White CA, Norman PA, et al. Performance of the 2021 Race-Free CKD-EPI Creatinine- and Cystatin C-Based Estimated GFR Equations Among Kidney Transplant Recipients. Am J Kidney Dis. 2022. PMID: 35588905. doi:10.1053/j.ajkd.2022.03.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。